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Abstract
A Geographical Examination of social, behavioral, and demographic determinants association
with Hepatitis C Viral Infection in the State of Georgia
(Under the direction of Dr. Richard Rothenberg, Faculty Member)

Background: Approximately 170 million persons are infected with the hepatitis C viral infection
(HCV), globally. Of this number, 3.2 – 4 million persons in the U. S. are infected with HCV. Although
previous research has indicated a decrease in the rates of Hepatitis C in the U.S. approximately 12,000
deaths occur annually from those who suffer from chronic liver disease, as a result of being chronic
carriers of HCV. Being a recipient of blood transfusions prior to 1992, intravenous drug users (IDUs),
or persons with multiple sex partners are associated with increased risk for HCV infection. IDUs
constitute the largest cohort for those infected with HCV. Due to the few clinical manifestations HIV
and HCV share and HIV patients living longer due to Highly Active Antiretroviral Therapy (HAART),
Many individuals infected with HIV are discovering co-morbidities with HCV.
Methods: Secondary Data from the State Electronic Notifiable Disease Surveillance System (SENDSS)
were used to analyze all confirmed cases of hepatitis C in the state of Georgia for the year 2009. All
subjects in this analysis were confirmed as Hepatitis C infected. Descriptive frequencies for all
categorical data were tested and analyzed, which included: gender, race, geographic region, disease
status, age distribution, risk factor data such as injection drug use, blood transfusion prior to 1992, long
term hemodialysis, accidental needle stick, tattoo, sexual contacts, and incarceration. Binary logistic
regression for univariate and multivariate analysis was used to test the associations between geographic
region of all HCV cases and their demographic characteristics.
Results: Descriptive analysis of the prevalence of HCV cases in Georgia in 2009 reveal higher rates of
HCV in rural regions (GOA) of the state among White males of non-Hispanic origin. In this same
region, these cases were more likely to report risk factors involving injection drug use, blood
transfusions prior to 1992, incarceration, or tattoos. Prevalence of most cases of HCV in Georgia for the
year 2009 are seen in those age 20 – 30 and those 40 – 60. A higher number of those reporting
intravenous drug use in metropolitan Atlanta (MSA) are Black of non-Hispanic origin. Bivariate
logistic regression reveals that White Non-Hispanics living in rural areas of Georgia (GOA) have a 3.48
higher odds of being infected with Hepatitis C than Black Non-Hispanics (OR = 3.48, p < 0.001, CI 2.54
– 4.77).
Conclusion: Resources for prevention of Hepatitis C should be directed to marginalized communities
within Georgia regions outside of the Atlanta Metropolitan Statistical Area. The primary focus of
prevention should also be tailored to new initiates of intravenous drug use and those 20 – 30 and 40 – 60
years of age. Further knowledge and understanding of behaviors that put individuals at risk for
acquiring Hepatitis C, such as intravenous drug use, in rural Georgia may warrant interventions tailored
to benefit these communities from acquiring or spreading Hepatitis C.
Key Words: Hepatitis C, Intravenous Drug Use, Georgia, Ethnicity, Risk Factors
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CHAPTER I
INTRODUCTION
1.1 Background
Hepatitis, inflammation of the liver, is a disease that results from the infection of the Hepatitis A
virus (HAV), Hepatitis B virus (HBV), the hepatitis C virus (HCV) or even the Hepatitis D and
Hepatitis E virus. Hepatitis C is the leading cause of death and reason for liver transplantation in the
United States and is even identified as a global issue with some three percent of the world‘s population
infected with the virus (World Health Organization Global Alert and Response, 2002) (Benoit, et al.,
2007). According to the Centers for Disease Control & Prevention, 2.7 – 3.9 million people are
chronically infected with HCV in the U.S. and approximately 12,000 deaths are reported annually from
chronic liver disease resulting from HCV infection.
Chronic Hepatitis C is a serious long term illness from the virus that can result in end stage liver
disease, cirrhosis, severe liver inflammation, or even death (Daniels, Grytdal, & Wasley, 2007). Reasons
for such results from chronic HCV infection are either due to lack of prophylaxis (no vaccines exist for
HCV) or lack of treatment and detection of the diseases during two to six months following exposure
(Georgia Division of Public Health -- Epidemiology, 2005).
HCV prevention primarily relies on early detection, testing, surveillance, and avoiding behaviors
that can put an individual at risk for infection (Daniels, Grytdal, & Wasley, 2007) (Georgia Division of
Public Health -- Epidemiology, 2005). Adding to the burgeoning issue of detection and treatment of
HCV is the difficult task of the healthcare practitioner, specialist, or even patient to recognize a disease
that may remain asymptomatic for some time (especially for children) (Georgia Division of Public
Health -- Epidemiology, 2005).
Acute Hepatitis C is a short term onset of the disease (usually the first six months after exposure)
when the classic symptoms of the HCV infection are seen, which include: abdominal pain, fatigue,
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jaundice, and through clinical diagnosis and detection high levels of aminotransferase (ALT/AST)
(Georgia Division of Public Health -- Epidemiology, 2005) (Seef, Strader, Thomas, & Wright, 2004).
Each year 17,000 new cases of HCV infection are seen in the U.S. (Centers for Disease Control
and Prevention, 2007). The prevalence of chronic HCV infection is nearly three times that of the HIV
infection and is expected to get worse in the coming years (Benoit, et al., 2007). The previous figure is
probably an underestimate of actual cases (Thomson, 2009) (Georgia Division of Public Health -Epidemiology, 2005). Some of the underreporting may arise from the difficulty of identifying the HCV
infection in those that remain asymptomatic for the disease.
Many cases infected with the Human Immunodeficiency virus are living longer due to the advent
of highly – active antiretroviral therapy (HAART), resulting in the reduction of morbidity and mortality
of those infected with HIV (Benoit, et al., 2007) (Oramasionwu, et al., 2009). On the other hand, many
of these cases are discovering that they are co-infected with the HCV infection because the spread of
both viruses are caused by similar common risk factors such as Intravenous Drug Use (IDU), blood
transfusions in patients before 1992, and certain sexual acts and behaviors (Benoit, et al., 2007).
As of 2003 there was a plateau in the rates of Hepatitis C in the state of Georgia, which followed
a sharp decline in the rates after a high peak in 1992. Hepatitis A and B rates in Georgia have exceeded
the national rate, while Hepatitis C rates have been difficult to determine and provided with estimates,
due to poor reporting and surveillance by clinical practitioners and patients. This dilemma can be due to
patients and practitioners‘ limited understanding of the HCV infection, lack of availability of HCV
informative resources and testing, or lack of funding and resources for state surveillance programs for
Hepatitis (Georgia Division of Public Health -- Epidemiology, 2005).
Taking the previous issues into account, Georgia faces an issue in identifying true and accurate
reportable numbers of Hepatitis C cases, when in reality we could already be experiencing rates that
parallel or exceed that of the national rate of HCV cases. Such numbers and investigation of where the
2

disease is prevalent in Georgia, and who is experiencing most of the burden of this disease will also
show where most of the states resources should be allocated for the diagnosis, treatment, and prevention
of the disease (cf. recent Doonesbury). Through further study and investigation of such areas and
populations can help public health practitioners identify risk factors and behaviors unique to these areas
and populations that cause the spread of the Hepatitis C Virus.

1.2 Purpose of Study
The purpose of this study is to determine the association of geography, race/ethnicity, and other
demographic factors with Hepatitis C rates in the state of Georgia. Hepatitis C is believed to be a
growing burden in the U.S. While Hepatitis A & B rates in Georgia have been reported to exceed the
national Hepatitis A & B rates, Hepatitis C rates have been estimated to plateau in Georgia after 1992.
Such ―estimates‖ of rates are either due to poor reporting, lack of surveillance programs, availability
clinical information and resources to providers, and patients on HCV infection, and limited awareness
and prevention efforts among high-risk populations (Georgia Division of Public Health -- Epidemiology,
2005). Through studying and understanding the various risks for HCV among various populations and
geographical arenas in Georgia, a lucid understanding of where resources for diagnosis, treatment, and
prevention should be focused on in Georgia and identifying various unique aspects which set such
populations and geographical regions at more risk for HCV infection than others.

1.3 Research Questions
This investigation will add to any existing literature on Hepatitis C morbidity and mortality in
Georgia. Questions addressed in this research will include: Are White non – Hispanic individuals
living in Georgia are more at risk for Hepatitis C than Black non-Hispanic individuals living in Georgia?
Does this difference in risk correlate with geographic region in which the cases reside whether it is in the
3

Atlanta Metropolitan Statistical area (MSA) or Georgia Outside of Atlanta (GOA)? Are age and gender
associated in a difference in risk for Hepatitis C. Finally, is there an association between geographic
regions and certain social and behavioral activities that may put individuals at risk for Hepatitis C?

1.4 Hypothesis
Georgia, as well as the U.S., shows a plateau in estimated rates of HCV infection, but limitations
hinder public health officials in investigating further into the activities and risk taking behaviors
involved in populations most at risk for infections. What prevents such further investigation is that most
of the risk taking behaviors associated with the transmission of HCV infection is caused by behaviors
that are considered criminal, such as intravenous drug use. With the lack of resources and funding in
public health in Georgia, lack of access to primary care, minimal active surveillance, risk taking
behaviors, methamphetamine use, in rural Georgia, and Georgia as a major drug trafficking hub Georgia
will experience a rise in HCV infection rates especially in white non-hispanic males living in rural
Georgia or Georgia Outside of Atlanta (GOA).

With the lack of resources and funding, lack of access to primary care, and risk taking behaviors
in urban areas around and in Atlanta, and Atlanta being one of the major drug trafficking hubs in
America, there will be a rise in HCV infection rates in black non-hispanic individuals living in Atlanta‘s
Metropolitan Statistical Area (MSA). Rates of HCV infection differ significantly based on race and
ethnicity in accordance to various demographic regions in the state of Georgia. Whatever rates of HCV
infection one ethnic group may experience in Metro Atlanta could differ for the same ethnic group in
rural Georgia, therefore Geography plays a critical role in further investigating the burden of HCV
infection in Georgia.
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CHAPTER II
REVIEW OF THE LITERATURE
The purpose of this study is to determine the association between Hepatitis C Viral Infection
rates in the state of Georgia in accordance to demographic factors such as race/ethnicity, gender, and
geography. Further investigation on injection drug use (IDU), the number one risk factor for HCV
Infection, within the Atlanta Metropolitan Statistical Area (MSA) and Georgia Outside of Atlanta
(GOA) regions of Georgia as well as ethnic/racial makeup of these respective regions were needed to
determine which populations and regions in Georgia are experiencing higher rates of HCV infection.
From this information and further analysis it could also be concluded which population of individuals
and regions in Georgia are more at risk for seeing an increase in rates of HCV infection, therefore
revealing the regions and populations in Georgia where public health officials should focus their
prevention strategies.

2.1 Hepatitis C Viral Infection: Case definitions and Clinical Manifestations
Non – A hepatitis, non – B hepatitis, as the Hepatitis C Viral (HCV) Infection was originally
called, was first identified in the 1960s (Benoit, et al., 2007) (Georgia Division of Public Health -Epidemiology, 2005). The virus was first seen in the post-transfusion population prior to 1992. Since

1992 screening is now mandatory prior to any process involving blood transfusions and blood donations,
thus lowering the risk of acquiring HCV (Benoit, et al., 2007).

The Hepatitis C Viral infection is the leading cause of chronic liver disease and is a virus in
which the magnitude of infection is difficult to determine and is underestimated due to various clinical
manifestations of the virus (Thomson, 2009) (Georgia Division of Public Health -- Epidemiology,
2005). 85% of those infected develop chronic infection (Georgia Division of Public Health -- Epidemiology,
5

2005). The hepatitis virus is a small enveloped virus containing a positive single stranded RNA genome

(9600 nucleotides in length) (Thomson, 2009). The virus attacks the adaptive immune response of the
individual, thus making it more likely for individuals exposed to develop the chronic illness of HCV. It
is not uncommon for those infected with HIV to be co-infected with HCV. In such a case the
consequences of HCV infection are more severe. This occurrence is common due to the shared risk
factors the viruses have (Chung & Kim, 2009).

Due to HAART therapies and other multidrug treatments for HIV, those infected and clearing
HIV are suffering less mortality, but cannot rule out the chance of co-infection with HCV (Georgia
Division of Public Health -- Epidemiology, 2005) (Chung & Kim, 2009) (Alter, et al., 1999). Due to the
implementation of therapies for HIV, such as HAART, the once known fatal disease of HIV has
transformed itself into a debilitating chronic infection (Chung & Kim, 2009). Since the introduction of
highly active antiretroviral therapy (HAART) and the improved survival rate for HIV infected patients,
HCV and its complications (such as progressive acceleration of liver disease) have become the main
source of morbidity and mortality in the IDU population of person‘s infected with HIV, therefore HIV
patients should be screened for HCV infection, a practice that has not yet been widely implemented due
to the slow progression of the clinical nature of HCV (Chung & Kim, 2009) (Alter, et al., 1999)
(Dienstag, 2006).

Co-Infection with HIV and HCV increases the morbidity and mortality experienced by infected
patients. A prospective observational cohort known as HOPS studies and analyzes patients receiving
care at ten outpatients public and private clinics in Chicago, IL, Denver, CO, Long Island, NY, Oakland,
CA, Philadelphia, PA, San Leandro, CA, Tampa, FL, and Washington DC. This is an ongoing and open
cohort where patients, after a diagnosis with HIV, can enter the study and leave the study at any time.
From 1996 to 2007, of 7618 patients who were active in HOPS, the proportion of patients with positive
6

HCV diagnosis increase from 10.7% - 76.6% in the clinics (8-fold increase), taking into account that the
number of active patients in HOPS during 1996 – 2007 varied (Spradling, et al., 2010). These results
show that by following the 1999 guidelines of testing all HIV infected individuals for HCV, regardless
of risk, a significant number of co-infected cases can be identified and treated promptly to reduce
morbidity and mortality.

Acute HCV is a discrete onset of symptoms such as Jaundice, elevated amino transferase levels
(>400 IU/L) (Daniels, Grytdal, & Wasley, 2007). Several methods can be used in detecting HCV which
include testing for antibodies to HCV with EIA (enzyme immunoassay) and using HCV RNA to
measure the presence of viremia. Amino-transferase (ALT/AST) levels higher than normal account for
the presence for acute HCV infection. Those infected with acute HCV may go through a 2 to 6 week
phase of the virus being undetected (asymptomatic) and such acute infections, due to the lack of preprophylactic actions unlike Hepatitis A and Hepatitis B (no vaccine exists for Hepatitis C), and lack of
detectability, can lead to chronic infection, cirrhosis, and severe liver inflammation (Georgia Division of
Public Health -- Epidemiology, 2005) (Daniels, Grytdal, & Wasley, 2007).

Those who develop chronic hepatitis C may experience a serious progression of illness leading to
severe long term liver scaring and inflammation. Seventy to 90 percent of individuals infected with
HCV fail to clear the virus during the acute phase (Daniels, Grytdal, & Wasley, 2007) (World Health
Organization Global Alert and Response, 2002). Five -20 percent may develop cirrhosis while 5% of
those infected with HCV may die from long term infection (World Health Organization Global Alert
and Response, 2002). Intravenous Drug use is the number one risk factor for acquiring HCV infection
and intravenous drug users (IDUs) constitute the largest population of those infected with the virus in
developed nations (Thomson, 2009). Injection drug use has also been the number one public health
concern for the spread of infectious disease such as HIV, HBV, HCV, and the co-infections of both
HBV and HCV with HIV (Tempalski, 2007).
7

Hepatitis C is known to be hyper-endemic in the IDU population with a prevalence reaching
90% at times (Lelutiu-Weinberger, et al., 2009). Other risk factors include receiving blood transfusions
prior to 1992, long term hemodialysis, health care work, sexual contact with those infected, multiple sex
partners, men who have sex with men (MSM), infants born to infected women, incarcerated individuals,
and receiving tattoos administered with unsterilized equipment (Georgia Division of Public Health -Epidemiology, 2005). According to a prevalence study done in the United States from 1988 – 1994,

among all racial and ethnic groups, on HCV infection, increased prevalence of the virus was reported to
be associated with persons who had a history of cocaine or marijuana use, early stage of first sexual
intercourse, higher number of sexual partner, infection with herpes simplex virus II, and were engaged
in intravenous drug use and high-risk sexual behavior (Chung & Kim, 2009) (Alter, et al., 1999)
(Garfein, Vlahov, Galai, Doherty, & Nelson, 1996).

Higher rates of HCV infection were found among non-hispanic blacks and non-hispanic white
male subjects, this in turn projects a visual stigma upon non-Hispanic Blacks, due to the higher
distribution of disease seen in such populations, along with these same subjects testing positive for HIV
(Garfein, Vlahov, Galai, Doherty, & Nelson, 1996) (Alter, et al., 1999). Higher prevalence of HCV
infection was found in those 30 – 49 years of age and those living below the poverty level; no
association was found between the prevalence of HCV infection and geographic region of residence for
an individual (Alter, et al., 1999). Although IDUs are primarily responsible for the increase in
prevalence for HCV infection, initiates to injection drug use are at higher risk for HCV infection than
experienced drug users, due to high rates of viremia occurring within the first few months of initiation
(Garfein, Vlahov, Galai, Doherty, & Nelson, 1996). New initiates and short term drug users, although at
increased risk compared to their counterparts who are more experienced IDUs, do not display high risk
sexual activity or higher risk injection practices that will further increase their risk for HCV infection
(Garfein, Vlahov, Galai, Doherty, & Nelson, 1996).
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Since 2004 the incidence of HCV has hit a plateau for all racial and ethnic populations except for
American Indians and Alaskan Natives. In 2007 rates were similar across all racial and ethnic
population. In that same year, the most common risk factor reported for HCV was Intravenous Drug Use
(48%) (Daniels, Grytdal, & Wasley, 2007) (Centers for Disease Control and Prevention, 2007). 42%
reported having multiple sex partners, while 10% reported having contact with another known HCV
infected individual, 10% were MSM, and 2% reported occupational exposure to blood infected with
HCV. After rates for HCV hit a peaked in the late 1980s and early 1990s there was a decline in the
incidence through the rest of the 1990s due to recognition of intravenous drug use (IDU) as the number
one risk factor for HCV and the decline of IDU activity through the rest of the 1990s. Required
screening for blood products and donors in the early 1990s also contributed to the decline of HCV rates.

A long term prospective study of HCV showed among 895 monogamous heterosexual partners
of individuals chronically infected with the virus (total follow p period of more than 8000 person-years)
found a low or null risk of sexual transmission (Alter, et al., 1999) (Thomson, 2009). Men who have sex
with men (MSM) are experiencing an increase in acute HCV infection, especially among those in this
population already infected with HIV (Thomson, 2009). Transmission in this group can be correlated
with per-mucosal as opposed to per-cutaneous methods of transmission, number of sexual partners,
sharing of drugs through nasal route, a high number of sexual partners, and high risk sexual activity
(Thomson, 2009) (World Health Organization Global Alert and Response, 2002). Most studies still
show less than a 5% risk of mother to infant transmission, with those co-infected with HCV and HIV
twice as likely to transmit HCV than those infected with HCV alone. Screening, testing blood donors,
viral inactivation of plasma-derived products, risk-reduction counseling, screening of persons at risk for
HCV infection, and routine practice of infection control in health care settings are examples of ways to
address primary prevention practices to reduce the risk of HCV Transmission.
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National surveillance for viral hepatitis started in 1966. During 1995-2007, rates for all three
types of acute hepatitis declined due to effective surveillance of the virus and effectiveness of the
Hepatitis A and Hepatitis B vaccines (World Health Organization Global Alert and Response, 2002).
Co-factors for disease progression of HCV include increased age at disease progression, alcohol intake,
and MSM practices. Natural history in the progression of HCV shows that in the U.S. HCV will rise
and the some of the same models predict that deaths from HCV will rise by the year 2030 (Thomson,
2009). Accurate and reliable surveillance of HCV is critical in altering this projected trend.
Surveillance detects outbreaks and identifies those in need of post exposure prophylaxis, provides
information on trends occurring due to the infection and within the cohorts infected, the collection of
risk data, and the development of prevention strategies.

2.2 Hepatitis C Viral Infection: A Global Overview of the Prevalence and Burden of HCV

Hepatitis C is a major issue in both Developing and Developed nations around the world
(Alavian, Ahmadzad-Asi, Lankarani, Shahbabaie, Ahmadi, & Kabir, 2009). IDUs account anywhere
from 30% - 60% of the global HCV infection rate. Many studies have estimated the incidence of new
infections for HCV globally to be approximately 40 per 100 person-years at risk (Rhodes & Treloar,
2008). A case-control study that was conduced in four counties in china, through data collected from
HCV screening, showed how HCV infection prevalence differ based on geographic region, time, and
behavioral changes (Cai, et al., 2009). Prevalence of HCV in China was approximately 3.2% of the
country‘s population, but studies have placed the prevalence of HCV in China anywhere from 0% - 30%
depending upon the region.

In developing countries the main risks for HCV infection are iatrogenic factors like inadequate
sterilization, reuse of medical equipment, or blood transfusion (Reeler, 2000). This trend can be seen in
10

many developing nations where injections are given with faulty and unsatisfactory sterilization practices
due to insufficient knowledge or lack of equipment (Reeler, 2000). In the previous study in Anyang,
China persons who were sero-positive for HCV were enrolled in a case-control study where the
association between three risk factors for HCV known in this region were examined: esophageal balloon
examination (OR=3.78), blood transfusion (OR=4.55), Intravenous drug use (OR=5.83).In some
developing countries there have been no overall estimate of HCV infection prevalence, or no review of
published evidence related to HCV for the purpose of providing an accurate estimation of the prevalence
of HCV infection of the general population. Iran is an example of one such country; until a formal
systematic review of all HCV related reports from were collected from various research and medical
related institutions (Alavian, Ahmadzad-Asi, Lankarani, Shahbabaie, Ahmadi, & Kabir, 2009).

Transmission through exposure to infected blood or blood products, infected medical equipment,
intravenous drug use, hemodialysis, and organ transplantations were associated with risk of infection for
Hepatitis C in both developing and developed nations globally, including countries such as Iran, an
infection that affects approximately 170 million world wide (Alavian, Ahmadzad-Asi, Lankarani,
Shahbabaie, Ahmadi, & Kabir, 2009). In Iran, 0.08%-1.3% of the general population in 2006 was
infected with HCV (Alavian, Ahmadzad-Asi, Lankarani, Shahbabaie, Ahmadi, & Kabir, 2009). Rate of
occurrence in groups such as IDUs, and patients undergoing long term hemodialysis was seen in such a
group in Iran and even for other nations globally. This study also proved that epidemiologic evidence is
one main strategy that is crucial in attaining information on prevalence of such an infection, for the
purpose of prevention.

Accurate and efficient data collection on HCV infected cases are important to public health for
the purpose of establishing rational strategies in order to further comprehend the morbidity and mortality
associated with chronic HCV infection throughout various known cohorts at risk for the infection
(Thomson, 2009). In this study, prevalence varied according to province in Iran as opposed to the study
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in Anyang, China which shows no correlation of HCV infection with geography. In Iran, provinces
bordering neighboring countries encountered a higher risk and prevalence of HCV infection than those
more populous and centered within the country (Alavian, Ahmadzad-Asi, Lankarani, Shahbabaie,
Ahmadi, & Kabir, 2009). In a cohort study in Trent, England (N = 2285) participants from various
secondary care clinics were matched to other representative HCV-infected populations in England.
From this study, it was found that HCV-infected persons experience a death rate three times higher than
that of their age matched population due to Chronic drug use (Thomson, 2009).

A national survey, conducted ten years ago, showed the prevalence of antibodies (anti-HCV) of
individuals in metropolitan France, ages 20 – 29 years, to be approximately 1.05% (500,000 – 600,000
persons when extrapolated to the French population) (Meffre, et al., 2010). Due to the national health
insurance system set up in France, demographics information was collected from participants based on a
five region stratified and multistage sampling design. This study shows that in metropolitan France antiHCV prevalence in 2004 was 0.84% (95% Confidence Interval (CI): 0.65 – 1.10) for individuals ages 18
– 80 (Meffre, et al., 2010). Prevalence was not statistically different for males and females.

An increase in prevalence was seen in those individuals with less than 12 years of education,
low socioeconomic status, and those unemployed. For both males and females, prevalence of anti-HCV
was highest for those ages 40 – 80 years of age (Meffre, et al., 2010). An increase in prevalence was
seen in those who were recipients of blood transfusion prior to 1992, those who reported ever injecting
drugs, and for those reporting nasal drug use, (3.7%, p = 0.02), (55.7%, p = 0.01), and (9.3%, p = 0.01)
respectively (Meffre, et al., 2010). Prevalence was also high in those reporting previously having
surgery, needle stick injury, tattooing, and more than 10 sex partners. This population based
seroprevalence survey demonstrates another global case in which HCV presents itself as a burden to a
developed nation.
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Most HCV infections are asymptomatic or mildly symptomatic with a continual progression in
infection seen in 85% of cases (World Health Organization Global Alert and Response, 2002). Risk of
Hepatocellular Carcinoma (HCC) can be seen mainly in groups living with cirrhosis. One-third of all
cases of HCC in the U.S. and 90% of cases HCC in Japan are associated with chronic HCV (World
Health Organization Global Alert and Response, 2002) (Meffre, et al., 2010). Chronic Hep C progresses
at different rates depending on the infected individual. Antiviral Therapy should be advised for patients
suffering or at risk of developing chronic HCV. Liver biopsy is usually necessary to uncover the
histologic stage of the disease progression for determining what therapies are needed. Injection drug
users constitute the largest group of those infected with Hepatitis C. Some studies have shown that
Blacks have less favorable antiviral kinetics than whites, therefore they experience a lower than normal
response rates to antiviral treatment. Some of these disparities have yet to be explained.

Seroprevalence of HCV can vary based on geography globally and specific risk factors in
association with the infection in a particular region, as the study in Iran tried to prove (Hepburn &
Lawitz, 2004). A study in Haiti on the seroprevalence of HCV tried to further investigate geographical
and risk factor data in its association with the prevalence of HCV in the country. Intravenous Drug Use
(r = 0.26, p < 0.001), intranasal cocaine use (r = 0.29, p < 0.001) and the number of lifetime sex partners
(r = 0.24, p < 0.001) were all found to be statistically significant in their positive correlation with respect
to HCV prevalence. In such a model, intravenous drug use and the number of sexual partners were
associated with HCV infection (OR 3.7, 1.52 - 9.03 95% CI; OR 1.1, 1.04 - 1.20 95% CI, respectively)
(Hepburn & Lawitz, 2004).

These data were representative of the urban population of Haiti, which has been the focus of
many studies globally. Limited data and risk factor information in rural populations and high risk
populations globally and in the U.S. limit further investigation of the burden and prevalence of hepatitis
C. Although the incidence of infection is falling in some countries the burden of chronic infection from
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HCV continues to rise. Intervention strategies proven through much evidence from studies, such as
syringe exchange and distribution programs, are needed to prevent this trend from occurring or else a
considerable rise in morbidity and mortality from HCV may be experience by the year 2030 (Thomson,
2009) (Rhodes & Treloar, 2008). However, barriers still exist against the enhancement of prevention
methods against HCV such as national policies that prevent the delivery of care to those infected with
HCV, such as IDUs (Thomson, 2009).

2.3 Hepatitis C Viral Infection: United States Overview of the Prevalence and Burden of HCV

As of 2007, 849 Acute HCV cases (0.3 cases /100,000 people) were reported nationally from an
estimated 2800 cases (Centers for Disease Control and Prevention, 2007). In the U.S. in 1982 the
reported number of cases were 2629 (1.1 cases/100,000 persons), 1991 there were 3582 reported cases
(1.4 cases/100,000 persons) in the U.S., 1992 there were 6010 reported cases (2.4 cases/100,000
persons) in the U.S., and in 2001 there were 1640 reported cases (0.7 cases/100,000 persons) in the U.S.
Cases of acute HCV are reported voluntarily to CDC through state Health Departments via CDC‘s
National Notifiable Disease Surveillance System (NNDSS) (Daniels, Grytdal, & Wasley, 2007). For
cases each cases reported data is collected on the event date, source of report, demographics, laboratory
test results, clinical information, and exposure history.

In 2007 cases were required through CDC to meet a standard clinical definition for acute
hepatitis and laboratory criteria for diagnosis had to be met based on guidelines set by CDC. The clinical
guidelines are as follows: discrete onset of symptoms such as nausea, anorexia, malaise, or abdominal
pain, jaundice, and elevated serum amino-transferase levels above 400 (Daniels, Grytdal, & Wasley,
2007). Laboratory Guidelines for acute HCV diagnosis include IgM anti-HAV and IgM anti HBV are
both negative and one of the following, anti-HCV (antibody) or HCV RIBA are positive (Centers for
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Disease Control and Prevention, 2007) (Daniels, Grytdal, & Wasley, 2007). In the U.S. acute viral
hepatitis C (non-A, non-B hepatitis became reportable in 1982, from 1982-1991 the prevalence of
reported hepatitis C were unreliable reflecting inaccuracy, error in the methods for reporting and
surveillance (Daniels, Grytdal, & Wasley, 2007).

Many individuals living in the U.S. with Hepatitis C are asymptomatic, which accounts for an
overall prevalence of HCV in the U.S. that was 1.8%, corresponding to approximately 3.9 million
persons living with HCV in the U.S. (95% CI, 3.1-4.8 million persons). Sixty-five percent of HCV
infections occur in those individuals 30-49 years of age, 74% of these cases are chronically infected
(approximately 2.7 million persons, 95% CI 2.4-3.0 million) (Alter, et al., 1999). The incidence of acute
Hepatitis C can be traced through a trend which reach a peak in 1992 then declined rapidly after 1992,
attributable to a decrease in incidence of IDUs as well as a change in behaviors and practices of IDUs.
As of 2003 rates have hit a plateau. In 2007 a total of 849 (0.3 cases/100000) cases of acute Hepatitis C
were reported nationally. Rates HCV hit a plateau in 2003 only to experience a slight increase in 2007
within the age group of 25 – 39 year olds (0.5 cases/100000) and those over 40 years of age (Daniels,
Grytdal, & Wasley, 2007). Before such an increase in rates in 2007, there was a 90% decrease in HCV
infection rates in 25 – 39 year olds from 1990 – 2007, a cohort that has historically seen the highest rates
of disease for HCV (Daniels, Grytdal, & Wasley, 2007). Few cases are reported in those 15 years of age
and younger, possibly due to those in the cohort experiencing a high rate of asymptomatic characteristics
of HCV.

In 2007, the reported rate of HCV was higher in males than in females for persons 15-34 years of
age (0.5 : 0.8 : 1.0 for 15-19 year olds, 20-24 year olds, 25-29 year olds, and 30-34 year olds
respectively) (MMWR).Among those 17-59 years of age, the strongest independent factors that are
associated HCV infection include illegal drug use and high-risk sexual behavior, having 12 or less years
of education, having been divorced or separated (Alter, et al., 1999). In the U.S., of the 2.7 million
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persons chronically infected with HCV, with most of these persons involved in illegal drug activities and
high risk sexual behavior (Alter, et al., 1999). Approximately one-half of the new cases of HCV and
one-third of the HIV/AIDS cases reported are attributable directly or indirectly to injection drug use in
the U.S. (Jones, Burris, Junge, Sterk, & Taussig, 2002). The prevalence of patients with acute Hepatitis
viral infection in accordance to selected epidemiological characteristics, by age group, are reported in
table (2.1).

In a U.S. study conducted in association with University of Cincinnati School of Medicine and
the Harvard School of Medicine a cohort of patients was studied based on various demographic
characteristics and the prevalence of Hepatitis C infections among those co-infected with HIV. Data
from this study shows 650,000 - 900,000 persons in the U.S. infected with HIV, the HCV prevalence
within this cohort was 1.8% (approximately 3.9 million residents of the U.S, with 65% of those coinfected being between the ages of 30 - 49 (Sherman, Rouster, Chung, & Rajicic, 2002). Required HCV
screening for those already infected with HIV is beneficial, and CDC supports this guideline in
accordance to the evidence previously mentioned (Sherman, Rouster, Chung, & Rajicic, 2002).
Treatment and therapy for injection drug users is treated on a case by case basis. Clinical trials have
been used to determine the most effective treatment and prevention methods fore patients infected with
HCV. With IDUs composing most of the population of those infected with HCV, this population should
be considered as the main focus of such clinical trials and research in testing preventive measure against
HCV and treatment and therapy for HCV.

Hepatitis C in the US accounts for approximately 40% of all chronic liver disease with 800010000 deaths reported annually from the infection (Dienstag, 2006). The most common cause for liver
transplantation is due to infection from Chronic Hepatitis C with the prevalence higher among 40-59
year olds and Blacks of non-hispanic decent (Dienstag, 2006). Results of from many studies and
surveillance fail to capture the true number of those infected, turning out low estimates of the disease
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prevalence, because they fail to capture high risk (marginalized) populations such as injection drug users
(IDUs), incarcerated persons, and the homeless. Based on computer cohort simulation models, the U.S.
is expected to experience $10.7 billion in direct medical expenditures for HCV related treatment
between 2010-2019 (Dienstag, 2006). Without pre-prophylactic treatment for HCV, prevention is
centered upon proper blood screening of blood and organ supplies and changes in behaviors that put
individuals at risk for the infection. Most diagnosis of chronic Hepatitis C is made by medical
serendipity, due to asymptomatic individuals participating in blood drives or other various medical
exams.

Public Health practitioners have seen the need for further prevention of HCV through counseling
and educating non-infected persons at risk for the infection, a strategy that is in great demand in high
risk populations (Daniels, Grytdal, & Wasley, 2007). Post-exposure prophylaxis is needed along with
these prevention strategies to reduce the rate of transmission and development of sequelae from chronic
liver disease. National surveillance data Hepatitis C provides necessary information to develop
prevention strategies and monitor effectiveness of such prevention strategies. Accurate and completed
data only reflects accurate reporting from labs, health care providers, and public health practitioners,
therefore education and knowledge on recognition and diagnosis of hepatitis C is crucial.

Primary care, social service, and syringe exchange programs provide direct clinical intervention
in the prevention of the spread of infectious disease. Federal law has been the reason for cause for
dispute against such social and intervention programs. Federal law tends to ignore benefits of these
multifaceted programs and state governments are left with the decision of analyzing, based on
geography, the benefit and placement of these interventions (Tempalski, 2007). Accurate and completed
data only reflects accurate reporting from labs, health care providers, and public health practitioners,
therefore education and knowledge on recognition and diagnosis of hepatitis C is crucial. As of the year
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2000 154 SEP programs were operating in the U.S. with major concentration in geographic clusters
within the Northeastern U.S. and West (Tempalski, 2007).

2.4 Hepatitis C Viral Infection: State of Georgia Overview of the Prevalence and Burden of HCV
Of all the acute hepatitis C cases reported in Georgia in 2007, only 0 – 10% included risk factor
data based on case investigation and follow up (Daniels, Grytdal, & Wasley, 2007). Georgia‘s rates of
acute Hepatitis A and B have exceeded national rates, but rates for Hepatitis C remain difficult to
determine due to a number of factors such as poor reporting, limited clinical information on Hepatitis C,
health care practitioners and patients lack of understanding and recognition of symptoms, especially for
those asymptomatic or Co-infected with HIV (Georgia Division of Public Health -- Epidemiology,
2005). Limited options for free or low cost testing exist in the state of Georgia which adds to the lack of
capturing exact numbers of those infected. Lack of Hepatitis C awareness among medical providers,
limited options for inmates whose parole is scheduled before treatment is completed, and insufficient
prevention efforts among high risk populations have proven to be issues in Georgia especially in
capturing the prevalence of Hepatitis C cases.

In 2001 Georgia saw approximately 151,302 cases of Hepatitis C, which accounted for 1.8% of
its population (Georgia Division of Public Health -- Epidemiology, 2005). In 2002 and 2003 Georgia
saw approximately 153,114 cases and 156,324 cases respectively (Georgia Division of Public Health -Epidemiology, 2005). Table (2.2) provides an overview of the number of cases per 100000 persons from
1995-2007 in the state of Georgia.

Georgia has and continues to make efforts in the prevention and accurate reporting of viral
hepatitis C cases through emphasizing and prioritizing resources that are placed on the burgeoning
issues of hepatitis C. Plans have been placed to target populations that are at risk for the virus for the
18

sake of prevention. In January of 2004 the Georgia Department of Public Health was notified by the
Council of State and Territorial Epidemiologists (CSTE) that it was one of the six states to be awarded
with funds to develop programs for the prevention, reporting, and recognition of the state‘s viral
hepatitis issues. Prioritization criteria were formulated through this plan which included: length of
implementation, impact on target audience, and goals/evaluation measures.

Prevention strategies in various regions around the U.S., such as syringe exchange programs, are
highly debated and create a barrier to the enhancement and education of utilizing prevention strategies
due to discrepancies in laws and regulations on a state by state basis. Georgia is an example of a state
where no lawexist on banning the exchange of syringes (Jones, Burris, Junge, Sterk, & Taussig, 2002).
The debate reflects on whether health care professionals and pharmacists should possess the decision on
prescribing or exchanging syringes to individuals who partake in risk taking behaviors for HCV and
HIV, in order to prevent the reuse of such drug injection equipment. There are also opinions on whether
law making officials, through their bureaucratic agendas, should hold up critical public health issues and
leave the issue as a state and congressional law making decision (Jones, Burris, Junge, Sterk, & Taussig,
2002). Some state governments have refused to ever fund syringe exchange programs (SEPs), even
though these programs have shown to reduce the burden transmission of infectious diseases such as
HCV (Tempalski, 2007).

Georgia, like many of its southern neighbors such as Alabama consists of at least one major
metropolitan region, Atlanta, a rural mountainous region a part of the Appalachian mountain chain, and
an outlying region of rural counties in the southern region of the state. Many of its southern rural
counties are identified as a part of the Black Belt, a region that stretches from the Carolinas through
Georgia, Alabama, Mississippi, and Louisiana (Lichtenstein, 2007). This region, quoted as being home
to some of the ―richest‖ soil and poorest people in the U.S. was once home to large thriving cotton
plantation in the 19th century. This region is also over 50% African American, many of whom are
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descendents of slaves who have never left the region after the American Civil War (Lichtenstein, 2007).
Since the Civil War this region has been plagued with a lack of industry, employment, and healthcare.
This region is also a venue to the largest disparity seen in infectious disease transmission such as HIV
and HCV and marginalized populations in risk taking behaviors promoting the transmission of
infectious diseases (Lichtenstein, 2007).

Studies in HIV and HCV infection rates and risk factors have been carried out some
communities and healthcare clinics in these rural and poverty stricken areas of the American South.
Studies in HIV clinics in rural Alabama have been used in analysis in defining the rates of infectious
diseases such as HIV and HCV and how they correlate to illicit drug use in rural areas within the black
belt region. Poverty and health disparities were also taken into account for such analysis. Transmission
of infectious diseases such as HIV has been shown to vary by geography and demographics. One
illustration of this trend can be seen in the 1980s where the disease was primarily seen in Whites in
urban regions and cities within the U.S. (Lichtenstein, 2007). Of the HIV cases reported in Alabama in
2004, Blacks represented 70% of that number. IDU was not recognized as the number one risk factor
for the transmission of the disease (Lichtenstein, 2007).

An HIV/AIDS clinic in rural Alabama was the focus of a study in 2004 where 27 men and 20
women, approximately five-percent out of a total of 1,189 patients, identified themselves as IDUs, most
of whom were white (Lichtenstein, 2007). Studies also show that crack-cocaine use and sex-for-drug
exchange was the number one risk factor for HIV transmission for African American Women living in
rural Alabama. In rural Alabama, in a region such as the black belt, such multifaceted trends of drug use
and risk factors are highly likely to be represented in regions of similar make-up in Georgia
(Lichtenstein, 2007). Small isolated pockets of population also contribute to risk behaviors and sexual
practices that put this disproportionate population of African Americans and even some White
Americans at risk for infectious diseases like HIV and HCV.
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Georgia, just like its neighboring states to the north, consists of a rural Appalachian mountainous
region, a region known for excessive risk behaviors such as IDU and methamphetamine use. In this
region exists cases of HBV and HCV, reported to their respective state health departments, sharing the
same risk factor of intravenous drug use (Christian, Hopenhayn, Christian, McIntosh, & Koch, 2010).
Kentucky, which has published a report on IDU through its rural health department, has had cases
reported to their state department, CDC, and NNDSS, reporting clinical and epidemiological
manifestations for the increase in the incidence of HBV and HCV cases seen in the eastern regions of
the state (the Appalachian region). Small cities in Eastern Kentucky such as Hazard, Kentucky
(population of 4,867 in 2006) experience high poverty and unemployment rates and are the center of a
location that experiences high HCV rates (Christian, Hopenhayn, Christian, McIntosh, & Koch, 2010).

For this study in Kentucky, surveys and pre-screening questionnaires were administered to health
departments who saw HCV cases routinely receiving any testing. With such a small number of
participants within the study and the descriptive analytic nature of this study descriptive statistics was
the focus for the study. Of the 92 participants in this study approximately 45% of these individuals were
18 – 29 years of age and approximately 43.5% were 30 – 49 years of age (Christian, Hopenhayn,
Christian, McIntosh, & Koch, 2010). 32.6% reported having less than a high school education while
70.7% of respondents reported being unemployed (Christian, Hopenhayn, Christian, McIntosh, & Koch,
2010). Approximately 63% receive some form of government assistants (Christian, Hopenhayn,
Christian, McIntosh, & Koch, 2010). 53 participants were patients referred to their respective health
department clinics in Eastern Kentucky, due to reported risk factors. Of this number, approximately
15% tested positive for HCV (Christian, Hopenhayn, Christian, McIntosh, & Koch, 2010).

While no descriptive analytical literature on HCV infection, its risk factor, and demographic
characteristics exist in Georgia, the state does share similar characteristic social and behavioral trends, as
seen in the Alabama and Kentucky studies, that put its population at risk for the Hepatitis C viral
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infection (Rural Substance Abuse Partnership, 2010). Georgia also remains as a significant drug
distribution center in the Southeastern United States, and as a result the Georgia Bureau of Investigation
(GBI) and Drug Enforcement Administration (DEA) has made numerous drug violation arrests (804
arrests of drug violators) and task force efforts resulted in 2,618 arrests of drug offenders from 2001 –
2002 (Office of National Drug Control Policy, 2009). In 2000 the National Household Survey reported
approximately 1.2% of citizens in Georgia are dependent on illicit drugs (Rural Substance Abuse
Partnership, 2010) (Office of National Drug Control Policy, 2009).
Cocaine, Heroin, Methamphetamines, and Marijuana are Georgia‘s principal drug threat. What
the first three have in common is the choice of the user to dissolve the drug and inject it, a risk factor in
itself for HCV, especially when the injection equipment is being reused (Office of National Drug
Control Policy, 2009). The transport of such drugs are possible due to Georgia‘s highway system where
all major North to South and East to West thoroughfares traverse through rural areas of Georgia and
either cross or converge within Atlanta. Georgia boasts a major international airport in Atlanta as well
as major sea ports in Savannah and along its coast, making Georgia accessible to drugs being smuggled
into the states and as a major drug trafficking state (Office of National Drug Control Policy, 2009).
Georgia is also a destination en route from major cities such as Miami and has seen an influx Hispanic
population growth, which has helped in the ease of transporting illegal drugs from Mexico into the states
(Office of National Drug Control Policy, 2009). This activity does nothing to abate the risk and
behaviors for infectious diseases such as HCV and will promote the increase in cases of HCV in Georgia
(Office of National Drug Control Policy, 2009).
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2.5 Hepatitis C Viral Infection: Geographical and Cultural Overview and Conception of HCV

Social geography for Injection Drug Users (IDUs) defines the constructions place and space,
whether it is through activities and behaviors, economics, and political and social influences such as
establishment and movement of space (impact of police drug crackdown). Place can be defined as space
(in the terms of geography) with meaning and time (Tempalski, 2007) (Cooper et al, 2004; Cresswell,
2004; Kearns and Joseph, 1993) Injection drug users also define what public health officials call a
marginalized or ―hidden‖ population in which one or more common attributes are shared and among
such a population and hidden from public scrutiny and surveillance due to the stigma and legality
associated with the activity (Poon, et al., 2009). As a result this makes it difficult to measure and find
true effects and associations in a behavior and its associated risks (Poon, et al., 2009). Such hidden
populations are the focus of the transmission of infectious diseases such as HCV, surveillance, and
social networks for intervention of risk factors such as intravenous drug use.
One example can be analyzed in the year 2000, the 46th precinct in the Bronx, NYC was selected
as a site for qualitative observation and research involving the study of IDUs behaviors and practices in
injection drug use as well as social and geographic structure of the community. According to the 2000
census, over 90% of the precinct identified themselves as African American and/or Latino, 40% lived
under the federal poverty level (Cooper, Gruskin, Krieger, & Moore, 2005). In this study population
most individuals were African American or Latino, most of whom had never obtained more than a high
school level education. One-third of the participants considered themselves homeless (Cooper, Gruskin,
Krieger, & Moore, 2005). Most participants reported engaging in one or more unsafe injection practices
including re-using their own syringes and borrowing previously used syringes and other injection
equipment, the primary cause for Hepatitis C viral infection.

Approximately one-third of the participants lived in the public sphere in areas controlled by the
precincts affected by drug crackdowns and Injection drug use (Cooper, Gruskin, Krieger, & Moore,
23

2005). Those living in these areas were either homeless or living in overcrowded home and would inject
outside the area of heavy police trafficking or minimize the time spent injecting through unsafe injection
practices that posed a health risk for Hepatitis C and HIV (Cooper, Gruskin, Krieger, & Moore, 2005).
This was all done to evade police prosecution.

A qualitative study in a New York City police precinct in 2000, which involved 40 illicit drug
injecting residents, illustrates how IDUs hesitate to engage in safe injection practices as a result of fear
from police crackdowns and legal fallout (Cooper, Gruskin, Krieger, & Moore, 2005). IDUs are more
likely to endanger their own health, through borrowing injection equipment, and not cleaning the
equipment or injection site prior to injection; IDUs were more likely and willing to risk their own health
than face the legal consequences of their actions. Ethnicity also played a critical role in the perception
of safe injection practices versus legal prosecution. African Americans are more fearful of arrest and are
more likely to engage in unsafe injection practices as opposed to their Caucasians (Cooper, Gruskin,
Krieger, & Moore, 2005). Arrests from drug possession in the U. S. more than doubled from 1982 –
2001 (540,000 – 1,279,000) as opposed to the 1960s – 1980s where upper level drug distributers had a
monopoly on the trade of drugs (Cooper, Gruskin, Krieger, & Moore, 2005) .

Today street and local level distributors nationwide are more prevalent and as a result
surveillance, arrests, and policing strategies have been heightened to counteract this behavior (Cooper,
Gruskin, Krieger, & Moore, 2005). Public Health has tried to take on the controversial role in
advocating and supporting efforts in reducing the morbidity and mortality for IDUs in various
communities in the U.S., as a result of unsafe injection practices. Through the concept of harm
reduction, public health practitioners involved in the 2000 New York City police precinct crackdown
study were interested in how to protect the health of IDUs living in those particular communities as well
as preventing transmission of the infection to non-using communities. One practice in harm reduction
involves proper access of treatment and education for drug users in the community (Cooper, Gruskin,
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Krieger, & Moore, 2005). To further illustrate the practices and behaviors of IDUs under geographical
and social constraints of a precinct under heavy prosecution and surveillance for drug crackdowns,
testimonies from similar qualitative studies were provided.
Participant: I have a little bottle of water [I] stick the syringe in it , put the syringe [in the cooker]… that‘s it.
Interviewer: And no time to cook?
Participant: No, no time for nothing. Whether it‘s good or bad I‘m going to be taking a chance.

38 year old black woman

Due to HIV and HCV sharing similar clinical manifestations and transmission routes, research
has tried to determine whether the same disparities seen in HIV cases which are unevenly distributed by
race and ethnicity hold similar to that of HCV cases. With limited studies on HCV and such analysis on
demographic variability when it comes to the HCV infection it has been difficult to say that Blacks and
Hispanics, as in HIV cases, are disproportionately infected with HCV as well (Lelutiu-Weinberger, et
al., 2009). Disproportionality of race and ethnicity within the IDU population and other risk taking
behaviors for HCV may explain the variability in transmission rates in certain populations infected with
HCV. Further investigation is needed to identify various levels and positions in society, such as race,
social, risk/social networks of IDUs, economic, and cultural and how such ecological models impose
variability in transmission rates among certain populations. In turn, through analysis of such models
intervention strategies can identify clear foci.

As a result of such studies public health has intensified its study of the transmission of infectious
diseases various ecological levels and networks in the clinical, social, and behavioral sciences. Public
health has also taken and included the concept of risk environment in further analyzing how geography
(defined by place, persons, and time) and the various economic, social, and political conditions define
such space and influence the dynamics of disease (Cooper, Bossak, Tempalski, Des Jarlais, & Friedman,
2009).
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One such subcultural observation can be seen in inner city (urban) areas across the U.S. which
harbors a disproportionate number of blacks. Intolerable conditions, hopelessness, alienation, and racial
discrimination have been only a few factors that perpetuate the risk behavior in such communities, such
as the sale and trade of drugs for either the financial reward or an escape from intolerable realities facing
such individuals (Joseph & Pearson, 2002). This environmental exposure induces the risk for HCV,
HBV, or HIV infection (Joseph & Pearson, 2002). Public health has also addressed the issues of the
disproportionate numbers of blacks incarcerated within the U.S. especially due to non-violent drug
related offenses. This brings up the issue of whether law enforcement surveillance underreport drug use
and possession within suburban and outlying communities as opposed to their urban counterparts. Drug
related behaviors that put individuals at risk for HCV is about the same for blacks (7.4%) and whites
(7.2%) and a little less for Latinos (6.4%), but the question always remains why black (60% of the
incarcerated population in the U.S.) and other persons of color make up most of the prison population
(Elkavich & Moore, 2008)? Are other areas, that contain high drug trafficking routes and manifest high
drug use being overlooked, such as the outlying areas and bedroom communities of a metropolis that we
least expect.

Meta-ethnographic approaches through review of various qualitative studies on IDUs have also
been used account for the risk perception injecting drugs and the possibilities of acquiring Hepatitis C.
In a study conducted through the University of London‘s Centre for Research on Drugs and Health
Behaviour, seven themes were created through analysis across a number of literature on the risk
perception on Injection drug use and acquiring Hepatitis C. Regular IDUs who belong to social network
that consistently demonstrate risky injection behavior are more likely to be less concerned of their risk
of acquiring HCV and adopt a role of HCV and Intravenous Drug Use as their identity, as opposed to
their counterparts who are less engaged in Intravenous drug use; those persons tend to harbor more of a
concern for acquiring HCV infection (Rhodes & Treloar, 2008).Another concern through Rhode‘s &
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Treloar‘s study is the issue of HCV taking a back seat to HIV when it comes to the knowledge and
importance of concern.

Many individuals and IDUs create a relative viral risk between HIV and HCV, which distorts the
importance of one infection over the other. HIV receives the greater attention clinically and through the
media is viewed as the more stigmatic (Rhodes & Treloar, 2008). Lack of knowledge on HCV also
creates a perception for many individuals, in which these individuals see HCV not being as great of a
concern as HIV. These individuals harbor that attitude of, ―It doesn‘t matter whether I acquire Hepatitis
C, I am more concerned of HIV‖, an attitude that can be dangerous and life threatening (Rhodes &
Treloar, 2008).Certain folk medicine and cultural practices have been linked to the transmission of HCV
within various populations such as acupuncture, ritual scarification, body piercing, tattoos, and
commercial barbering (Daniels, Grytdal, & Wasley, 2007). The lack of awareness, education, and ability
to properly sterilize and dispose of equipment used in such practices propagates the spread for HCV
infection in these populations and within others.

High risk individuals not only include IDUs, transfusion recipients prior to 1992, or those with
multiple sex partners, but also refugees from countries with high rates of HCV infection (Daniels,
Grytdal, & Wasley, 2007). Efforts have been continuously made to ensure that this population is
screened and properly documented through the national surveillance system. An uneven geographic
distribution of infectious diseases such as HCV in the U.S. can be seen as a result of the lack of public
health initiative to assess the geographic variability through analysis with HCV risk factors and
demographics (Tempalski, 2007).
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Chapter III
METHODOLOGY

3.1 Data Sources
The State Electronic Notifiable Disease Surveillance System (SENDSS) for the state of Georgia
was the source for data collection and secondary data extraction for the purpose of this research. The
unit of analysis for this study was each confirmed hepatitis C case within the state of Georgia for the
year 2009. For the purpose of this study, the study design that was considered and best suited for the
research was conducting a descriptive analysis by taking this cross-section (the year 2009) for all
confirmed cases of HCV for the state of Georgia and analyzing all descriptive characteristics for
confirmed HCV cases such as gender, race, disease status, geographic region, and all risk factors such as
injection drug use, blood transfusion prior to 1992, long term hemodialysis, accidental needle stick,
tattoos, sexual contact with HCV infected individual, and incarceration. For the purpose of this study
only Non-Hispanic Blacks and Whites were included.
A query was performed through SENDSS in order to obtain all variables of interest for both
Confirmed Acute and Chronic Viral Hepatitis C cases in the state of GA, for the year(s): 2009. Data
were collected for 2009 Hepatitis C cases through laboratory reports mailed or faxed from laboratories
such as Quest, Laboratory Corporation of America (Labcorp), the Georgia State Public Health Lab, and
other various microbiology laboratories in Hospitals throughout the state of Georgia. Demographic
information such as race, ethnicity, age, gender, patient identification, date of birth, county, address,
laboratory information, and other clinical information was extracted from each report and entered into
their respective variables in SENDSS. The ability to update and enter in new cases of HCV infected
individuals in SENDSS is dependent upon the resources, time, and the capacity of staff in hospitals,
doctor‘s offices or even laboratories.
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Information not included in lab reports sent to the state health department was therefore
considered missing. Disease status was also crucial to collect in order to receive accurate reporting and
numbers of which Hepatitis C cases in the state of Georgia for a given period of time were considered
acute or chronic. In order to receive such information Hospital Infection Control Practitioners and
private practice nursing staff were contacted for the receipt of vital clinical information such as signs,
symptoms, and laboratory measures (amino-transferase, RIBA, HCV RNA, anti-HCV) and tests not
indicated on the lab in order to confirm whether the case was acute and chronic. CDC guidelines for
interpretation of HCV test results were utilized by state and local health departments to confirm a case
as chronic, acute, or infected (needing further testing). Also, other demographic information not
indicated on labs faxed into the state health department was received through contacting the clinical
personnel previously mentioned.
All HCV cases confirmed as acute or chronic were subjected to immediate attention by district
public health practitioners for follow up, case reviewing, and case reporting for the sake of receiving risk
factor and behavior information as well as communication of prevention measures to those infected and
interviewed. Such risk factor questions contained in the follow-up case reporting forms on SENDSS for
the purpose of this study included: Have you ever been or are currently an injection drug user, Have you
ever received a blood transfusion prior to 1992, have you undergone long term hemodialysis, have you
received any tattoos, Have you ever been accidentally stuck by a needle, have you had sexual contact
with someone infected with HCV, have you ever been incarcerated. These questions were provided for
all cases infected with HCV in the state of Georgia in 2009 via local, district, and state health offices for
follow-up.
3.2 Study Variables
Variables of interest include: Patient ID, Zip Code, Address, County, Gender, Age, Race, Disease
Status, Confirmed Cases, Year(s) of Onset, and risk factor data. Risk factor data were collected through
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case reports the respective Georgia Health District in which a confirmed acute or chronic HCV case
reside. risk factor data of interest include: injection drug use, blood transfusion before 1992, long term
hemodialysis, accidental needle stick, tattoo, sexual contact, and incarceration.
A query was conducted on the State Electronic Notifiable Disease Surveillance System to extract
all confirmed Hepatitis C cases in all 159 Counties in GA. Of all these cases, cases for only the year
2009 were extracted from the raw data, as well as cases only confirmed as chronic, acute, and infected.
Both Males and Females, and all ethnicities and races were selected from the query criteria.
For geographical analysis purposes, zip code and street address for each case were collected, as
well as county of residence. Of Georgia‘s 159 counties, a specific code was assigned to each county
based on Georgia‘s Emerging Infectious Disease Program (GA-EIP). GA-EIP is a collaborative project
with Emory, CDC, and other state health Departments, who take part in active surveillance and research
studies on infectious diseases and outbreaks. GA-EIP activities are geographically divided in to two
regions that consist of specific counties, Atlanta and the surrounding Metropolitan Statistical Area
(MSA) and Georgia Outside of Atlanta and its surrounding metropolitan statistical area (GOA). MSA
counties were assigned a code of ‗1‘ while the remaining counties, GOA, were assigned a code of ‗2‘
For this study other metropolitan statistical areas outside of Atlanta such as Macon (Bibb
County), Augusta (Richmond County), Savannah (Chatham County), Columbus (Muscogee County),
and Athens-Clarke County, were not considered as MSA in order to retain consistency within the study
based on Georgia‘s EIP guidelines for what is considered MSA and GOA.
Gender was coded as follows, Male = 1, Female =2. Race was coded as, Whites = 1, Blacks = 2,
Others = 3 (include Hispanic, Asian, American Indian/Alaskan Native, Hawaiian/Pacific Islander, and
Multiracial). Those cases remaining unknown or with no data available for race were coded as ‗9‘. All
cases coded as ‗9‘ (Unknown) and ‗3‘ (Other races) were treated as missing cases for the sake of the
analysis, this included race, geographic region, disease status, and all risk factor variables.
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Risk factor case report questions including: Injection Drug Use, Blood Transfusion before 1992,
Long Term Hemodialysis, Accidental Needle Stick, Tattoo, Sexual Contact, and Incarceration were
provided with answers such as No, Yes, and Unknown. All questions marked as No under each risk
factor case report question was coded as ‗0‘. All questions marked as Yes were coded as ‗1‘. Those
questions marked as Unknown or not answered were coded as ‗9‘.

3.3 Study Population
The study population consisted of all confirmed cases of Hepatitis C Viral Infection reported to
the state of Georgia in 2009. These cases included all confirmed chronic and acute cases. “Infected”
cases were also included, infected cases were those who were confirmed as having HCV but not enough
information was collected on follow up of the case to proceed in confirming the case as chronic or acute.
All races were considered in this population. Both Male (N = 525) and Female (N = 330) were included
in the study population, and geography for the study population consisted of all counties within Georgia.
All ages were included in the study population, from birth to 88 years of age.

3.4 Statistical Analysis
Once the query was produced, the file containing all variables of interest was imported in
Microsoft excel 2003, recoded, and imported into the statistical software package SPSS 16.0, which was
utilized for the purpose for data analysis. All variables coded as ‗Unknown‘ or ‗Other‘ were treated as
missing cases. Normality for the distribution of each variable was confirmed through P-P plotting
through SPSS 16.0, from these results normality was assumed for age and parametric statistics were
utilized for the purpose of analysis.
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Descriptive statistics were run for all risk factor variables and all descriptive characteristics of
the study population which included gender, race, geographic region, and disease status. All variable for
descriptive characteristics and risk factors analyzed based on all data considered not missing, therefore
valid percents and totals were taken into account for all variables. Descriptive characteristics for all
HCV cases in Georgia were then illustrated through a bar graph (figure 1) which shows a proportion
(out of a total of 100%) for each number representative for a descriptive variable in the study. Risk
factor data were recorded for mostly acute cases as opposed to all other chronic or infected cases, again
reflecting the capability and resources necessary to complete follow-up and case reporting forms for all
HCV cases through the local health departments in Georgia.
All variables, except disease status, were coded as categorical data. Gender was coded as male
(1) and female (2). Race was coded as White Non-Hispanic (1), Black Non-Hispanic (2). Age was
distributed in 10-year age groups through 59, and 60+. Geographic region was coded based on county
designation as either being GOA or MSA based on Georgia EIP guidelines (MSA = 1, GOA = 2). Risk
Factor data such as injection drug use, tattoo, long term hemodialysis, blood transfusion prior to 1992,
sexual contact with infected individual, accidental needle stick, and incarceration were coded
categorically as either Yes = 1, No = 0, Unknown = 9. A chi-square test was run for all categorical risk
factor data and descriptive data, including age distribution, by geographic region. A chi-square test was
also run for these same descriptive characteristics, risk factors, and their distributions by Race (White
Non-Hispanic and Black Non-Hispanic) and geographic region (MSA and GOA).
Univariate and multivariate regression analysis was run for all descriptive characteristics and risk
factors as independent to geographic region as the dependent variable for the sake of controlling for
confounding within the analysis. Odds ratios and their 95% confidence intervals were then calculated
and tabulated in accordance to specified reference groups (Table 2.10, 2.11 respectively).
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Chapter IV
RESULTS

Of 855 persons infected with the Hepatitis C Viral Infection in the state of Georgia in 2009, 713
were chronically infected, 31 persons (based on CDC laboratory guidelines) were considered acute
infection, and 111 persons were infected without any confirmation on disease status on whether they
were chronic or acute. Males accounted for approximately two-thirds (61.4%) of the population. Of
that same cohort, White non-Hispanic individuals made up 55.4% while Black non-Hispanics made up
41.4% of the cohort. Within the year 2009 in the state of Georgia, of the confirmed HCV cases that
were reported, 55.9% of those reported cases were residents within areas outside of the Atlanta
statistical area (Georgia outside of Atlanta or GOA) while the remaining 44.1 were residents within the
Atlanta 28 county metropolitan statistical area. Table 2.1 shows the descriptive figures previously
mentioned for the 855 confirmed cases of HCV reported to the state of Georgia for 2009.

Of the total population in the study, 20% were reported as intravenous drug users or having
tattoos while approximately 4% reported being on long term hemodialysis. Sixteen and seven-tenths of
a percent reported receiving blood transfusions prior to 1992 while approximately 10% of those infected
with HCV reported having an accidental needle stick. Of the total population 10.6% reported sexual
contact with multiple partners. Of the total population, 12.5% are currently or had been incarcerated in
the past. Table 2.9 illustrates the various risk factors for the Hepatitis C Viral Infection and the figures
from confirmed reported cases for HCV, for Georgia in 2009, within this study identifiable within each
of the specified risk factors.

Age was treated as a continuous and categorical variable for this study. As a continuous variable
mean age for our all confirmed cases of Hepatitis C Viral infection in the state of Georgia for the year
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2009 was just under 50 years of age (47.4 years of age). As illustrated in table 2.3, each age category
was descriptively analyzed for 2009 confirmed cases of HCV in the state of Georgia. These data show
that approximately 13% of the cohort for confirmed HCV cases fall in the age range of 20 – 29, while
the age groups below this group (birth – 19) range anywhere from 0.6% - 1.6% of the total population of
confirmed HCV cases in Georgia for 2009. Individuals 30 – 39 years of age account for only 8% of this
cohort while ages 40 – 59 account for 23.4% and the age group of 50 – 59 years old accounting for
40.5%, largest percentage of confirmed HCV infected individuals in the state of GA for the year 2009.
Figure 2.1 illustrates the trend seen in table 2.2 for the Age distribution for individuals in 2009 in the
state of Georgia with confirmatory diagnosis of HCV.

Each descriptive characteristic chosen for this study (gender, ethnicity, and disease status) was
tested against the two regions of Georgia that were of focus for this study, Metropolitan Statistical Area
of Atlanta (MSA) and Georgia Outside of Atlanta (GOA), by using chi – square analysis. For previous
descriptive characteristics mentioned, Table 2.3 shows the distribution of Ethnicity, between White
Non-Hispanic and Black Non-Hispanic individuals, is statistically significant in accordance to residence
in either MSA or GOA (p < 0.001). Disease status, based on confirmation on whether the individual is
infected with acute, chronic, and undetermined status of HCV, is statistically significant in accordance
to residence in either MSA or GOA (p = 0.001). Gender was the only descriptive not statistically
significant in accordance to region of residence as either MSA or GOA (p = 0.15).

These results show us that there exists a significant difference in ethnicity (between White NonHispanic and Black Non-Hispanic individuals) based on region of residence in the state of Georgia, beit
MSA or GOA, in the state of Georgia in 2009. There also exists a significant difference in disease
status, whether an individual is diagnosed as chronic, acute, or undetermined (infected but confirmed)
disease status, based on region (GOA or MSA) or residence.
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Across all risk factors analyzed in this study which included Injection drug use, blood
transfusion prior to 1992, long term hemodialysis, accidental needle stick, tattoo, sexual contact, and
incarceration, not one showed any statistical significant value based on region of residence (MSA and
GOA) in the state of Georgia for the year 2009. Acute cases in the state of Georgia (N = 31; for the year
2009) require immediate follow-up and case reporting, which entails identification of risk factor data,
where as chronic cases in Georgia (N = 713; for the year 2009) which are the majority of cases require
case reporting, but the capacity to accomplish such a task is reflected upon the man-power and funding
from which the respective state grants to the district or state health office to carry out such a job.

Only 31 (acute) cases have a complete record of risk factor data. The results shown in table 2.8
reflects on how a large number of incomplete recorded risk factor data may show lack of statistical
significance based in accordance to certain dependent variables such as Geographic region. Across the
age distributions of ten years from birth to 60 years of age and older there exists no statistical significant
difference in accordance to the geographic regions of MSA and GOA.

Bivariate logistic regression was performed for various descriptive characteristics (dependent
variables) in their association with geographic region (independent variable). Considering all confirmed
HCV cases in the state of Georgia for 2009, results from Table 2.9 show that the only demographic
variable to show a significant association between geographic region was race (OR = 3.48, p < 0.001, CI
2.54 – 4.77). This result shows White non-Hispanic individuals infected with Hepatitis C have a 3.48
increased odds compare to Blacks of non-Hispanic origin to of residence in regions of Georgia outside
the Atlanta metropolitan statistical area.
Other demographic and risk factor variables that showed increased odds in their association to
geographic region were, Injection Drug Use (OR = 2.78, CI 0.68 – 11.44) and Tattoos (OR = 1.27, 0.32
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– 5.08) (Table 2.9). After adjusting for demographic and risk factor variables for reduction of
confounding, a statistical significant association ceased to exist between race and geographic region as
well as a decrease in odds (OR = 2.20, p < 0.001, CI 1.14 – 25.6), while an increase in odds, not
statistically significant was seen in Gender in its association with geographic region (OR = 2.98, CI 0.27
– 33.5). Risk factor data including injection drug use, hemodialysis, blood transfusion prior to 1992,
accidental needle stick, sexual contact, tattoos, and incarceration showed little to no association to
geographic region (0.999 – 1.00), while only blood transfusion prior to 1992, accidental needle stick,
and incarceration displayed increased odds in with no association to geographic region (Table 2.10).

Chapter V
DISCUSSION AND CONCLUSION

5.1 Discussion
Prevalence studies conducted in various geographic regions within developing countries and in
the U. S. indicate that minorities such as Blacks, Hispanics, and American Indian/Alaskan Natives are
experiencing the highest numbers of rates for HCV infection (Alter, et al., 1999) (Daniels, Grytdal, &
Wasley, 2007) (Oramasionwu, et al., 2009). This study indicates that geography plays a critical role in
determining who is truly at risk for HCV infection. Individuals infected with the hepatitis C viral
infection in regions of Georgia outside of the Atlanta metropolitan statistical area for the year 2009 were
more likely to be Whites of non-Hispanic origin. In rural Georgia, those infected with HCV most likely
were involved in risk factors that included injection drug use.
In order to further analyze the causes that justify these results, the demographic characteristics
within the geographic regions should be assessed. In the state of Georgia in 2009 there were two times
as many reported cases of HCV among males than females, while most cases were among white males
of non-Hispanic origin and chronic in nature. Most cases of HCV were reported among those
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individuals residing in areas outside of metro Atlanta and of reported risk factors, tattoos, blood
transfusions prior to 1992, and intravenous drug use were the most common risk factors.
Previous literature has shown that young adults (18 – 30 years of age) predominate as acute
carriers of HCV while most of the chronic carriers are seen in age groups 40 – 60 years of age. This
trend mainly reflects the availability, understanding, and focus of HCV testing prior to when guidelines
and recommendations were set in the 1990s. Those 40 – 60 years of age were possibly infected before
the advent of guidelines and testing for Hepatitis C, possibly before HCV was known as a clinical and
public health concern. Younger adults are exposed to recommedations and guidelines for testing as well
as education in recognition of the symptomology of acute hepatitis. A higher percentage of white-Non
Hispanic males infected with HCV reside in the GOA region, while a higher percentage of those
reporting intravenous drug use, reside in the MSA region of Georgia.
In accordance to the hypothesis previously stated in the study, analysis of the descriptive
characteristics support the hypothesis. Of those individuals infected with Hepatitis C in Georgia, a
majority of them happen to be male and of White non-Hispanic origin living in GOA. There exists a
significant difference based on race Compared to their counterparts living in MSA. Of all hepatitis C
cases in Georgia for 2009, although not significant in association, there exists an increased risk of
Injection drug use in GOA. Based on the review of literature many theories can account for the reason
for increased drug use and its cause in the increased prevalence of HCV infected individuals living in
GOA. Further analysis of drug trafficking routes and distribution points within the state of Georgia and
the demographic analysis of those active in the this risk taking behavior may just as well reveal the
reason for these trends.

5.2 Study Limitations
In determining prevalence and etiology of a disease a cross-sectional study has been used. In
this study various demographic variables were analyzed in their association with the prevalence of
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confirmed HCV cases within the state of Georgia in the year 2009. These data just capture a given
number of cases in a given period of time, therefore descriptive analysis in cross sectional study was
utilized. In such a study design, limitations do exist. This data utilized in this study are not
representative of every case including new (incident) cases, therefore when analyzing risk estimates we
are not observing a true and accurate association in what is really occurring (Gordis, 2009). Also, in a
study such as this, there is a loss of temporal relationship causing a discrepancy in the relationship of a
given risk factor and its association with HCV. We are left with wondering whether those infected with
HCV, who have displayed certain risks or behaviors that put others in danger of HCV, are the cause of
various trends presented in the data for this study and vice-versa (Gordis, 2009).
In conducting this research, review of previous literature pertaining to the social, geographical,
and ecological aspects on hepatitis C viral infection was crucial for proceeding to further analysis.
Existing literature on HCV highlights treatment, therapy, and the dynamics HIV has on the co-infection
with HCV, rather than the social, behavioral, or geographical variability of HCV. The limited amount of
literature similar in context to this study is only highlighted mainly on the national level rather than the
state level. Demographic characteristics within a national HCV cohort may not compare to what is seen
on a state wide, local, or community cohort for the same disease. Also, as in the case of this study
analysis on demographic characteristics in accordance to geographical associations on state level data
cannot be generalized on a national scale. Standardizing and weighting the data are both methods that
could‘ve assured meaningful results for the sake of comparing local to national data and results of
descriptive HCV prevalence.
Utilizing secondary data presents a limitation on this research. The source of this data was
provided through the State Electronic Notifiable Disease Surveillance System (SENDSS). First, data
retrieved from either laboratories or providers requires requests for sensitive patient information. Not all
staff within laboratories, clinics, or doctor‘s offices are familiar with the Health Insurance Portability
and Accountability Act (HIPAA) guidelines on reporting notifiable diseases to local and state public
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health officials in a times in a timely, accurate, and efficient manner. By utilizing these secondary data,
inaccuracies in associations in the data may be reflected upon by missing data, inaccuracies, and human
error in data entry into the states surveillance system. Table 1.5 illustrates the proportion of Acute
Hepatitis C cases with reported risk factor data, Georgia falls in the 0 – 10% range of Acute Hepatitis C
cases with reported risk factor data.
The growth of metropolitan and various geographic regions within Georgia indicates an issue in
delineating whether a certain area, based on population and availability of resources, should be
considered metropolitan or rural outside of Atlanta. The 10 – 20 county designation for metropolitan
Atlanta may vary based on personal opinion or standard guidelines such as the Georgia EIP guidelines.
This variability in county designation as MSA and GOA can cause discrepancies in the data and thus the
results when it comes to determining any associations between the variables and outcomes of interest
when analyzing disease prevalence and rates. Also, rural and urban distinction should have been taken
into account when analyzing the data. The data is not representative of the rural counties which contain
urban areas outside of Atlanta.
Due to inconsistencies in interpreting results for and disease status for confirmed HCV cases
information bias and misclassification of the subjects of study is seen within this study. Human
judgment and error as well as consistently following established guidelines set by the CDC for disease
status classification cause misclassified information in the surveillance database. With such surveillance
data, as presented in this research, too much focus for the confirmed HCV cases is placed on risk
factors, based on literature, known to promote the spread of HCV infection, such as intravenous drug
use, multiple sex partners, and blood transfusions. Not as much emphasis and analysis is placed on
other risk factors such as medical or surgical procedures that present a risk for HCV infection (Hepburn
& Lawitz, 2004).
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5.3 Recommendations

For the purpose of comparing data from state to national level and from national to state level
data, direct and indirect methods of standardizing the results that are analyzed is needed. This provides
a clear understanding how state representative data compares to national data. Also national level data
is represented through national level studies through CDC‘s Division of viral hepatitis; an element
lacking in state and local level literature on social, behavioral, and geographic aspects of the HCV
infection. Literature pertaining to the Social and ecological aspects on the role Intravenous drug users
play in the community also highlights social and geographical dynamics HCV may play on the local and
state level.
Through careful and accurate study of consistent and reliable surveillance data, reliable results
on future research for HCV can be produced as well as studies considering other risk behaviors
attributable to the spread of HCV that were never considered for previous study. Another method in
ensuring consistent and accurate data input occurs is consistent guidelines and recommendations in
disease status confirmation through CDC based the results of diagnostics used to test for the presence of
the hepatitis C virus. For future descriptive analytical studies on Hepatitis C standardizing the data, for
it be more representative of the population or region being studied, is critical when comparing the data
to the national data that is analyzing the same research question.

5.4 Conclusion

With injection drug use being the number one risk factor and public health concern for the spread
of infectious diseases such as HBV, HCV, HIV, and the co-infection of HIV with HBV or HCV,
prevention by using a collaborative effort of many strategies have to be made (Tempalski, 2007). Such
multi-faceted strategies include detoxification treatment programs, primary care, social service, and
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outreach networks for IDUs, and syringe exchange (SEP) programs (Tempalski, 2007). For these
programs to benefit the populations affected by the burden of HCV, geographical variability of the
disease has to be taken into account.
As analyzed in this study, a significant number of White non-Hispanic individuals reside in
Communities outside of Metro Atlanta. This cohort is also experiences greater odds of contracting
Hepatitis C infection due to Intravenous Drug Use. Understanding the dynamics and social behavior of
such communities may warrant possible strategies for intervention. It may take decisions based on the
opinions of those professionals within clinical medicine such as primary care practitioners, allied health
care practitioners, and pharmacists to advocate decisions such as the distribution of clean and sterile
syringes to such populations in order to reduce the burden of infectious diseases such as HCV.

Consistent, accurate, and reliable surveillance in rural Georgia regions also warrants the ability
to identify outbreaks, prevalence, rates of disease, and target a population in need of intervention and i
the case of HCV post-prophylaxis prevention strategies (Georgia Division of Public Health -Epidemiology, 2005). This also helps in the prevention in the development of chronic liver disease and
sequelae resulting from chronic infection of HCV. Methods to prevent this include identifying
behaviors that put an individual at risk for HCV infection and what initiates those behaviors such as
intravenous drug use, and risky sexual behaviors and establishing counseling and other post-prophylaxis
strategies to decrease the spread or initiation of HCV infection (Alter, et al., 1999) (Georgia Division of
Public Health -- Epidemiology, 2005).

Intervention for HCV should focus on new initiates in starting to inject drugs or display
behaviors that put them at risk for possible infection with HCV. Intervention for HCV should also be
focused on a specific target population that is at greater risk for HCV infection for the sake of more cost
effective prevention strategies, more focus in rural Georgia for males between the ages of 40 – 60 and
younger initiates to intravenous drug use. It has been noted in previous literature that one known
41

method in preventing the spread of the infection is to educate those who are already IDUs on safe
injection techniques in order for them to carry out these practices to new IDUs (Rhodes & Treloar,
2008). Populations who display such behaviors as injection drug use, and other taboo or risky behaviors
that put them at risk for HCV, have been known to be difficult contact, analyze, treat, and educate due to
the stigma or legal repercussions associated with their self identity as IDUs as being taboo, or their
sexual practices or sexual orientation.

A significant difference exists among ethnicity/race and gender, where White non-Hispanics
experienced more morbidity from Hepatitis C in rural Georgia counties and males experiences more
morbidity from Hepatitis C than females overall in Georgia in 2009. Identifying the dynamics, social
and ecological forces, disparities, and complexities plaguing various populations at risk for HCV is
crucial in the implementation and evaluation of Interventions prevention strategies to further decrease
rates of HCV and to eliminate the burden of the infection (Lelutiu-Weinberger, et al., 2009) (Reeler,
2000) (Cooper, Gruskin, Krieger, & Moore, 2005). It is important to understand how risk factors and
behaviors, known to put individuals at risk for HCV, are unique amongst various populations. Once
these behaviors are identified, prevention strategies then be evaluated and established once they are
tailored with respect to the culture, economic, and social climate of such societies and groups (Reeler,
2000). Although national rates for HCV have fallen in the U.S. certain populations such as IDUs
warrant particular attention for such prevention strategies to reduce the morbidity and mortality of HCV.
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Appendix 1

Table 1.1

TABLE 10. Number and percentage* of patients with acute hepatitis C who reported selected epidemiologic characteristics, by age group
— United States, 2007
Characteristic†

Age group (yrs)
<40§
No.

>40
(%)

No.

Total
(%)

No.

(%)

Cases reported with risk factor data
Injection-drug use

130/217

(59.9)

38/135

(28.1)

168/352

(47.7)

Sexual contact with
hepatitis C patient

8/51

(15.7)

1/39

(2.6)

9/90

(10.0)

Household contact
of hepatitis C
patient

2/51

(3.9)

3/39

(7.7)

5/90

(5.6)

Homosexual
activity (male)¶

5/33

(15.2)

1/25

(4.0)

6/58

(10.3)

2/215

(0.9)

6/143

(4.2)

8/358

(2.2)

Medical employee
with blood contact
Hemodialysis

0/200

(0)

2/136

(1.5)

2/336

(0.6)

>1 sex partner

67/140

(47.9)

30/91

(33.0)

97/231

(42.0)

Blood transfusion

0/204

(0)

0/135

(0)

0/339

(0)

Surgery

23/181

(12.7)

39/123

(31.7)

62/304

(20.4)

Percutaneous injury
(e.g., needlestick)

15/164

(9.1)

6/111

(5.4)

21/275

(7.6)

Unknown

71/243

(29.2)

71/163

(43.6)

142/406

(35.0)

Cases with no
reported risk
factor data
available

221

217

438

Total cases
reported

464

380

844

* The percentage of cases for which a specific risk factor was reported was calculated on the basis of the total number of cases for which any information for that
exposure was reported. Percentages might not total 100% because multiple risk factors might have been reported for a single case.
† Exposures that occurred during the 6 weeks–6 months before onset of illness.
§ A total of 34 (4%) patients were aged <19 years.
¶ Among males, 19% reported homosexual behavior.

Centers for Disease Control and Prevention. (2007). Disease Burden from Viral Hepatitis A,B,and C in the United
STates. Retrieved February 2010, from Centers for Disease Control and Prevention:
http://www.cdc.gov/hepatitis/HCV/StatisticsHCV.htm
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Table 1.2
Surveillance for Acute Viral Hepatitis – United States, 2007 (CDC/MMWR)

State
Georgia

1995
0.4

1996
N/A

1997
N/A

1998
0.1

1999
0.1

Years (1995 - 2007)
2000
2001
2002
0
N/A
0.7

2003
0.1

2004
0.2

2005
0.1

2006
0.1

2007
0.2

Incidence of acute Hepatitis C in the State of Georgia 1995-2007. (CDC/MMWR 2007).
N/A signifies data not available for any particular year as indicated on table ().
Cases are reported as ( number of cases/100000 persons).

Table 1.3 Disease Burden from Viral Hepatitis C in the United States
Hepatitis C
2007 2006
No. of Acute Clinical Cases Reported a
849
802

2005
694

2004
758

2003
891

2002
1,223

Estimated No. of Acute Clinical Cases b

2,800

3,400

4,200

4,500

4,800

Estimated No. of New Infections b
(current)

17,000 19,000 21,000 26,000

Percent Ever Infected c

3,200

28,000 29,000

1.3% - 1.9%

Number of Persons Living with Chronic
Infection d

2.7–3.9 million persons

Annual Number of Chronic Liver Disease
Deaths associated with Viral Hepatitis e

12,000

Centers for Disease Control and Prevention. (2007). Disease Burden from Viral Hepatitis A,B,and C in the United
STates. Retrieved February 2010, from Centers for Disease Control and Prevention:
http://www.cdc.gov/hepatitis/HCV/StatisticsHCV.htm
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Figure 1.1

Centers for Disease Control and Prevention. (2007). Disease Burden from Viral Hepatitis A,B,and C in the United
STates. Retrieved February 2010, from Centers for Disease Control and Prevention:
http://www.cdc.gov/hepatitis/HCV/StatisticsHCV.htm

Table 1.4 Incidence of Hepatitis C, United States

Year

Estimated Estimated
Acute
Total New
Cases
Infections

1982

29,500

180,000

1983

30,800

188,000

1984

36,000

219,000

1985

42,700

261,000

1986

43,000

262,000

1987

35,400

216,000

1988

39,400

240,000

1989

47,800

291,000

1990

29,400

179,000

1991

18,400

112,000

1992

12,000

73,000

48

1993

9,400

57,000

1994

8,900

54,000

1995

5,900

36,000

1996

5,900

36,000

1997

6,300

38,000

1998

6,800

41,000

1999

6,400

39,000

2000

6,300

38,000

2001

3,900

24,000

2002

4,800

29,000

2003

4,500

28,000

2004

4,200

26,000

2005

3,400

21,000

2006

3,200

19,000

2007

2,800

17,000

Centers for Disease Control and Prevention. (2007). Disease Burden from Viral Hepatitis A,B,and C in the United
STates. Retrieved February 2010, from Centers for Disease Control and Prevention:
http://www.cdc.gov/hepatitis/HCV/StatisticsHCV.htm
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Table 1.5

TABLE 1. Percentage of acute hepatitis cases that included risk factor data, by
state/area --- United States, 2007
85%--100%

61%--84%

11%--60%

0--10%*

Colorado

Alabama

Idaho

Alaska

Connecticut

Arizona

Kansas

California

Florida

Arkansas

Kentucky

Delaware

Hawaii

Indiana

Louisiana

Georgia

Iowa

Maryland

Texas

Illinois

Maine

Massachusetts

Virginia

Mississippi

Nevada

Michigan

Wyoming

Montana

North Carolina

Minnesota

New Hampshire

North Dakota

Missouri

New Jersey

Oklahoma

Nebraska

New York City

Rhode Island

New Mexico

Oregon

South Carolina

New York

Washington

Ohio

West Virginia

Pennsylvania
South Dakota
Tennessee
Utah
Vermont
Wisconsin

* No risk factor data were available for states in this category.

Centers for Disease Control and Prevention. (2007). Disease Burden from Viral Hepatitis A,B,and C in the United
STates. Retrieved February 2010, from Centers for Disease Control and Prevention:
http://www.cdc.gov/hepatitis/HCV/StatisticsHCV.htm
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Figure 1.2 Georgia EIP Regional Map

Grey = Metropolitan Statistical Area (MSA) for Atlanta
White = Georgia Outside of Atlanta (including rural Georgia)

CDC, Georgia Department of Community Health – Emerging Infectious Disease Program
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Appendix 2

Table 2.1 Basic Descriptive Characteristics of Hepatitis C Subjects in the State of Georgia (2009)
Variable

N

Percent (%)

Male

525

61.4

Female

330

38.6

White-Non Hispanic

407

55.4

Black-Non Hispanic

304

41.4

Other

24

3.3

MSA

368

44.1

GOA

467

55.9

Acute Hepatitis C

31

3.6

Chronic Hepatitis C

713

83.4

Hepatitis C (Infected)

111

13.0

Gender

Ethnicity

Geographic Zone

Disease Status

* Valid percent values are indicated for each value recorded for variables in the previous two tables.
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Table 2.2 Age Characteristics and Age Distribution Characteristics for Hepatitis C Subjects in the State
of Georgia (2009)
Variables

N

Mean ± SD

Minimum

Maximum

Age

855

47.4 ± 13.4

0

88

Age Distributions

N

Percent (%)

0–9

5

0.6

10 – 19

14

1.6

20 – 29

110

12.9

30 – 39

68

8.0

40 – 49

200

23.4

50 – 59

346

40.5

60 +

112

13.1

Figure 2.1
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Table 2.3 Geographic Distribution of Basic Descriptive Characteristics of Hepatitis C Subjects in the
State of Georgia (2009)
Geographic
Region

Variables (%)
Gender

Ethnicity (Non-Hispanic)

Male

Female

p-Value

White

Black

p-Value

MSA

63.6

36.4

.15

39.5

60.5

< .001

GOA

58.7

41.3

69.5

30.5

Geographic

†

Variables (%)

Region

Disease Status
Acute

Chronic

Infected

p-Value

MSA

4.3

88.0

7.6

0.001

GOA

3.2

80.3

16.5

†

† two – Assymp-sig.

Table 2.4 Geographic Distribution of Hepatitis C Risk Factor Data for the State of Georgia (2009)
Geographic
Region

Variables (%)
Injection Drug Use

Blood Transfusion Prior to 1992

Yes

No

p-Value

MSA

25.0

75.0

0.15

GOA

10.7

89.3

Geographic
Region

‡

Yes

No

p-Value

9.4

90.6

0.15

22.2

77.8

Variables (%)
Long Term Hemodialysis

*

Accidental Needle Stick

54

*

‡

Yes

No

p-Value

MSA

8.8

91.2

0.11

GOA

0

100

Geographic
Region

‡

Yes

No

p-Value

9.1

90.9

0.69

12.5

87.5

‡

Variables (%)
†

Tattoo

Sexual Contact

Yes

No

p-Value

MSA

18.8

81.2

1.00

GOA

15.4

84.6

Geographic
Region

‡

*

Yes

No

p-Value

15.6

84.4

0.30

0

100

‡

Variables (%)
*

Incarceration
Yes

No

p-Value

MSA

5.9

94.1

1.00

GOA

7.7

92.3

‡

* Two cells (50%) have expected counts less than five. Fischer’s exact test was utilized for these indicated variables
† One cell (25%) has expected count less than five. Fischer’s exact test was utilized for these indicated variables
‡ two – Assymp-sig.
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Table 2.5 Geographic Distribution Age Distribution for Hepatitis C Subjects in the State of Georgia
(2009)

Variables

‡

Geographic Zone

p-value

Percent (%)
MSA
Age Distribution (years)

GOA

*

0.23

0-9

0.3

0.9

10 – 19

1.6

1.7

20 – 29

10.6

14.8

30 – 39

6.0

8.6

40 – 49

26.4

21.6

50 – 59

41.6

40.3

60 +

13.6

12.2

* Two cells (14.3%) have expected counts less than five. Fischer’s exact test was utilized for these indicated variables

Table 2.6 Ethnic Distribution of Hepatitis C Risk Factor Data for the State of Georgia (2009)
Ethnicity
(NonHispanic)

Variables (%)
Injection Drug Use

†

Blood Transfusion Prior to 1992

Yes

No

p-Value

White

25.0

75.0

0.33

Black

12.5

87.5

‡
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Yes

No

p-Value

19.4

80.6

0.87

17.9

82.1

‡

Ethnicity
(NonHispanic)

Variables (%)
Long Term Hemodialysis

*

Accidental Needle Stick

Yes

No

p-Value

White

0

100

0.08

Black

10.7

89.3

Ethnicity
(NonHispanic)

‡

*

Yes

No

p-Value

13.3

86.7

0.69

8.7

91.3

‡

Variables (%)
†

Tattoo

Sexual Contact

Yes

No

p-Value

White

13.3

86.7

0.19

Black

29.2

70.8

Ethnicity
(NonHispanic)

‡

*

Yes

No

p-Value

12.0

88.0

0.63

5.6

94.4

‡

Variables (%)
Incarceration

*

Yes

No

p-Value

White

16.1

83.9

0.72

Black

11.5

88.5

* Two cells (50%) have expected counts less than five. Fischer’s exact test was utilized for these indicated variables
† One cell (25%) has expected count less than five. Fischer’s exact test was utilized for these indicated variables
‡ two – Assymp-sig
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Table 2.7 Ethnic Distribution of the Age Distribution for Hepatitis C Subjects in the State of Georgia
(2009)
Variables

Ethnicity (Non-Hispanic) (%)
Whites

Age Distribution (years)

p-value

Blacks

*

< 0.001

0-9

0.5

0.3

10 – 19

2.0

0.7

20 – 29

13.5

4.6

30 – 39

10.6

4.6

40 – 49

26.5

22.7

50 – 59

36.9

48.0

60 +

10.1

19.1

* three cells (21.4%) have expected counts less than five. Fischer’s exact test was utilized for these indicated variables

Table 2.8 Descriptive Characteristics of Hepatitis C Risk Factors for Hepatitis C Subjects in the State of
Georgia (2009)
Variable

N

Percent (%)

Yes

13

19.1

No

55

80.9

Yes

12

16.7

No

60

83.3

Yes

3

4.1

No

71

95.9

Injection Drug Use

Blood Transfusion Prior to 1992

Long Term Hemodialysis

58

Accidental Needle Stick
Yes

6

9.8

No

55

90.2

Yes

12

19.4

No

50

80.6

Yes

5

10.6

No

42

89.4

Yes

8

12.5

No

56

87.5

Tattoo

Sexual Contact

Incarceration

* Valid percent values are indicated for each value recorded for variables in the previous two tables.

Table 2.9 Relative Risk of living in GOA regions in the State of Georgia tested against Descriptive and
Risk Factor Variables (2009): Univariate Analysis
†

Geographic Region

Variable

MSA

GOA

1.00

0.81

Reference

0.61 – 1.08

1.00

3.48

Reference

2.54 – 4.77

1.00

2.78

Reference

0.68 – 11.44

p-Value

Gender
OR*
95%CI

0.15

Race
OR*
95%CI

< 0.001

Injection Drug Use
OR*
95%CI

59

0.16

Blood Transfusion Prior
to 1992
OR*

1.00

0.36

Reference

0.09 – 1.50

1.00

1.56x108

Reference

.000 -

OR*

1.00

0.70

95%CI

Reference

0.13 – 3.81

1.00

1.27

Reference

0.32 – 5.08

1.00

2.99x108

Reference

.000 -

1.00

0.75

Reference

.098 – 5.71

95%CI

0.16

Long Term Hemodialysis
OR*
95%CI

0.998

Accidental Needal Stick

0.68

Tattoo
OR*
95%CI

0.74

Sexual Contact
OR*
95%CI

>0.998

Incarceration
OR*
95%CI

0.78

* OR = Odds Ratio from univariate logistic regression analysis; CI = 95% confidence interval, p-value 2-sided
†
Geographic distinction (MSA and GOA) is being tested against demographic and risk factor variables containing
the specified reference as: gender (females), ethnicity (Black non-Hispanic), non- injection drug users, those
who have not had blood transfusions prior to 1992, not on hemodialysis, not victims of needle stick injury, no
tattoos, no sexual contacts HCV infected, not incarcerated.
‡ Low odds ratios and p-values that display no association for the risk factor data is reflective upon a large
number of missing data. Table 2.8 shows the percentage of each total number (N) of cases represented by their
respective risk factor.
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Table 2.10 Relative Risk of living in GOA regions in the State of Georgia adjusting against Descriptive
and Risk Factor Variables (2009): Multivariate Analysis

†

Geographic Region

Variable

MSA

GOA

1.00

2.98

Reference

0.27 – 33.5

1.00

2.20

Reference

0.19 – 25.6

1.00

< 0.001

Reference

.000 -

1.00

1.92

Reference

0.05 – 39.1

1.00

< 0.001

Reference

.000 -

OR*

1.00

1.51

95%CI

Reference

0.05 – 44.1

p-Value

Gender
OR*
95%CI

0.38

Race
OR*
95%CI

< 0.001

Injection Drug Use‡
OR*
95%CI

0.999

Blood Transfusion Prior
to 1992
OR*
95%CI
Long Term Hemodialysis
OR*
95%CI

0.84

‡

>0.998

Accidental Needal Stick
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0.81

Tattoo‡
OR*
95%CI
Sexual Contact
OR*
95%CI

1.00

< 0.001

Reference

.000-

1.00

< 0.001

Reference

.000 -

1.00

2.585

Reference

.000 -

0.999

‡

1.00

Incarceration‡
OR*
95%CI

1.00

* OR = Odds Ratio from univariate logistic regression analysis; CI = 95% confidence interval, p-value 2-sided
†

Geographic distinction (MSA and GOA) is being tested against demographic and risk factor variables containing

the specified reference as: gender (females), ethnicity (Black non-Hispanic), non- injection drug users, those
who have not had blood transfusions prior to 1992, not on hemodialysis, not victims of needle stick injury, no
tattoos, no sexual contacts HCV infected, not incarcerated.
‡ Low odds ratios and p-values that display no association for the risk factor data is reflective upon a large
number of missing data. Table 2.8 shows the percentage of each total number (N) of cases represented by their
respective risk factor.
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